Drug treatment of poststroke aphasia

References

• Kreisler A, Godefroy 0, Delmaire C et al The anatomy of aphasia revisited.Neurology54, 1117–1123 (2000).
   PubMed Web of Science ®Google Scholar
• Stegmayer B, Asplund K, Wester PO. Trends in incidence, case-fatality rate and severity of stroke in northern Sweden, 1985–1991. Stroke 25, 1734–1745 (1994).
   Google Scholar
• Kertesz A, McCabe P Recovery patterns and prognosis in aphasia. Brain 100, 1–18 (1977).
   PubMed Web of Science ®Google Scholar
• Laska AC, Hellbolm A, Murray V, Kahan T, von Arbin M. Aphasia in acute stroke in relation to outcome. J. Int. Med. 249, 413–422 (2001).
   Google Scholar
• Robinson RG, Bolduc PL, Price TR. Two- year longitudinal study of poststroke mood disorders: diagnosis and outcome at 1 and 2 years. Stroke 18, 837–843 (1987).
   Google Scholar
• Astrom M, Adolfsson R Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke 24, 976–982 (1993).
   Google Scholar
• Tennant A, Geddes JML, Fear J, Hillman M, Chamberlain MA. Outcome following stroke. Dis. Rehab. 19, 278–284 (1997).
   Google Scholar
• Pulvermuller F, Neininger B, Elbert T et al Constraint induced therapy of chronic aphasia after sbuke. Stmke 32, 1621–1626 (2001).
   Google Scholar
• Katz CR, Wertz RT. The efficacy of computer-provided reading treatment for chronic aphasic adults. J. Speech Language Hearing Res. 40, 493–407 (1997).
   PubMed Web of Science ®Google Scholar
• Aftonomos LB, Steele RD, Wertz RT. Promoting recovery in chronic aphasia with an interactive technology. Arch. Phys. Med. Rehab. 78, 841–846 (1997).
   Google Scholar
• Code C. Multifactorial processes in recovery from aphasia: developing foundations for a multileveled framework. Brain Lang. 77, 25–44 (2001).
   PubMed Web of Science ®Google Scholar
• Lincoln NB, McGuirk E, Mulley GP, Lendrem W, Jones AC, Mitchell JA. Effectiveness of speech therapy for aphasia stroke patients: a randomised controlled trial. Lancet 1, 1197–1200 (1984).
   PubMed Web of Science ®Google Scholar
• Wertz RT, Weiss DG, Aten JL et al Comparison of clinic, home and deferred language treatment for aphasia: a Veterans Administration co-operative study. Arch. Neural. 43, 653–658 (1986).
   PubMed Web of Science ®Google Scholar
• Robey RR. A meta-analysis of clinical outcomes in the treatment of aphasia. Speech Lang. Heating Res. 41, 172–187 (1998).
   PubMed Web of Science ®Google Scholar
• Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science 217, 855–857 (1982).
   Google Scholar
• Goldstein LB, Miller GD, Cress MM, Tyson AG, Davis JN. Studies of an animal model for recovery of function after stroke. Ann. Neural. 22, 159–160 (1988).
   Google Scholar
• Hovda DA, Feeney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res. 298, 358–361 (1984).
   PubMed Web of Science ®Google Scholar
• ••Provides evidence that the combinationof training with drug use (amphetamine) promotes neural plasticity in animal models of acute brain injury.
   Google Scholar
• Feeney DM, Hovda DA. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res. 342, 352–356 (1985).
   PubMed Web of Science ®Google Scholar
• Feeney DM, Hovda DA. Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. fiychophatmacology79, 67–71 (1983).
   PubMed Web of Science ®Google Scholar
• Meyer JS, Stoica E, Pascu I, Shimazu K, Hartman A. Catecholamine concentrations in CSF and plasma of patients with cerebral infarction and haemorrhage. Brain 96, 277–288 (1973).
   Google Scholar
• Porch B, Wyckes J, Feeney DM. Haloperidol, thiazides and some antihypertensives slow recovery from aphasia. Proc. Ann. Meet. Soc. Neum. 52, (1985).
   Google Scholar
• Cohen LG, Brasil-Neto JP, Pascual-Leone A, Hallett M. Plasticity of cortical motor output organisation following deafferentation, cerebral lesions and skill acquisition. Advan. Neural. 63, 187–200 (1993).
   PubMedGoogle Scholar
• Albert ML, Bachman DL, Morgan A Helm-Estabrooks N. Pharmacotherapy for aphasia. Neurology38, 877–879 (1988).
   Google Scholar
• Gupta SR, Mlcoch AG. Bromocriptine treatment of nonfluent aphasia. Arch Phys. Med. Rehab. 73, 373–376 (1992).
   PubMed Web of Science ®Google Scholar
• Raymer AM, Bandy D, Adair JC et al Effects of bromocriptine in a patient with crossed nonfluent aphasia: a case report. Arch Phys. Med. Rehab. 82, 139–144 (2001).
   PubMed Web of Science ®Google Scholar
• Sabe L, Leiguarda R, Starkstein SE. An open-label trial of bromocriptine in nonfluent aphasia. Neurology 42, 1637–1638 (1992).
   PubMed Web of Science ®Google Scholar
• Gold M, VanDAm D, Silliman ER. An open-label trial of bromocriptine in nonfluent aphasia: a qualitative analysis of word storage and retrieval. Brain Lang. 74, 141–146 (2000).
   PubMed Web of Science ®Google Scholar
• Sabe L, Salvarezza F Cuerva AG, Leiguarda R, Starkstein S. A randomised, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology45, 2272–2274 (1995).
   PubMed Web of Science ®Google Scholar
• Gupta SR, Mlcoch AG, Scolaro C, Mortiz T Bromocriptine treatment of nonfluent aphasia. Neurology45, 2170–2173 (1995).
   PubMed Web of Science ®Google Scholar
• Bragoni M, Alfieri M, Di Piero V, Padovani A, Mostardini C, Lenzi GL. Bromocriptine and speech therapy in nonfluent chronic aphasia after stroke. Neuro. Sci. 21,19–22 (2000).
   PubMed Web of Science ®Google Scholar
• Rossillon D, Vanwyck R,Bayet B, Calteux N, De Coninck A. The action of piracetam in ischaemic flaps. BE J. Plastic Surg. 40, 459–466 (1987).
   PubMedGoogle Scholar
• Vernon MW, Sorkin EM. Piracetam — an overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs Ageing 1,17–35 (1991).
   PubMedGoogle Scholar
• Waegemans T, Wilsher CR, Danniau A et al Clinical efficacy of piracetam: a meta-analysis. Dementia Geriatric Cog. Dis. 13, 217–224 (2002).
   PubMed Web of Science ®Google Scholar
• Enderby P, Broeckx J, Hospers W, Schildermans F, Debrendt W Effect of piracetam on recovery and rehabilitation after stroke. A double-blind, placebo-controlled study. Clin. Neuropharmacol17, 320–331 (1994).
   PubMed Web of Science ®Google Scholar
• Huber W, Willmes K, Poeck K, Van Vleymen B, Deberdt Wl. Piracetam as an adjuvant to language therapy for aphasia: randomised double-blind placebo-controlled pilot study. Arch Phys. Merl Rehab. 78,245-250 (1997).
   Google Scholar
• •Suggests that piracetam is useful in the treatment of aphasia when given together with conventional speech and language therapy.
   Google Scholar
• Darley FL. The efficacy of language rehabilitation in aphasia. I Speech Hearing Dis. 30,3–22 (1972).
   Google Scholar
• De Deyn P, De Reuck, Orgogozo JM, Vlietinck R, Deberdt W Treatment of acute ischemic stroke with piracetam. Stroke 28,2347–2352 (1997).
   PubMed Web of Science ®Google Scholar
• Orgogozo JM. Piracetam in the treatment of acute stroke. Pharmacopsychiatry 32(Suppl. 1), 25–32 (1999).
   Google Scholar
• Wade DT Measurement in Neurological Rehabilitation. Oxford University Press, Oxford, UK, 63–64 (1992).
   Google Scholar
• Kessler J, Thiel A, Karbe H, Heiss WD. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke 31,2112–2116 (2000).
   PubMed Web of Science ®Google Scholar
• •Demonstrates that piracetam improves cerebral blood flow in vivo in language areas. This observation suggests that rescue of the ischemic zone early after stroke may be responsible for the reported beneficial effects of this drug in aphasia.
   Google Scholar
• CaoY, Vikingstad EM, George KP, Johnson AF, Welch KMA. Cortical language activation in stroke patients recovering from aphasia with functional MRI. Stroke 30,2331–2340 (1999).
   Google Scholar
• Lee SM, Weisskopf MG, Ebner FE Horizontal longterm potentiation of responses in rat somatosensory cortex. Brain Res. 554,303–310 (1991).
   Web of Science ®Google Scholar
• Walker-Batson D, Curtis S, Natarajan R et al A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke 32,2093–2098 (2001).
   PubMed Web of Science ®Google Scholar
• Berthier ML, Hinojosa J, Martin MC, Fernandez I. Open-label study of donepezil in chronic poststroke aphasia. Neurology60, 1218–1219 (2003).
   PubMed Web of Science ®Google Scholar
• Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke. Cochrane Database Sys. Rev CD000424 (2001).
   Google Scholar
• Lazar RM, Marshall RS, Prell GD, Pile- Spellman J. The experience of Wernicke's aphasia. Neurology55,1222–1224 (2000).
   Google Scholar
• •Challenges the traditional assumptions regarding the clinical features of receptive aphasia. If this observation is confirmed, it may have important implications for aphasia rehabilitation.
   Google Scholar